These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 20185961

  • 1. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins.
    Kowalewski R, Malkowski A, Sobolewski K, Gacko M.
    Pathobiology; 2010; 77(1):1-6. PubMed ID: 20185961
    [Abstract] [Full Text] [Related]

  • 2. Influence of thrombophlebitis on TGF-β1 and its signaling pathway in the vein wall.
    Kowalewski R, Malkowski A, Gacko M, Sobolewski K.
    Folia Histochem Cytobiol; 2010 Dec; 48(4):542-8. PubMed ID: 21478096
    [Abstract] [Full Text] [Related]

  • 3. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.
    Friedl R, Li J, Schumacher B, Hanke H, Waltenberger J, Hannekum A, Stracke S.
    Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins.
    Jacob T, Hingorani A, Ascher E.
    J Vasc Surg; 2005 Mar; 41(3):523-30. PubMed ID: 15838489
    [Abstract] [Full Text] [Related]

  • 5. TGF-beta1 upregulation in the aging varicose vein.
    Pascual G, Mendieta C, García-Honduvilla N, Corrales C, Bellón JM, Buján J.
    J Vasc Res; 2007 Mar; 44(3):192-201. PubMed ID: 17337905
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins.
    Kowalewski R, Malkowski A, Sobolewski K, Gacko M.
    J Surg Res; 2009 Jul; 155(1):165-72. PubMed ID: 19394961
    [Abstract] [Full Text] [Related]

  • 7. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Rechberger T, Jakowicki JA, Krajewska WM.
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

  • 11. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A.
    Biochem J; 2002 Dec 15; 368(Pt 3):683-93. PubMed ID: 12223100
    [Abstract] [Full Text] [Related]

  • 12. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T.
    Clin Cancer Res; 2001 Jun 15; 7(6):1618-26. PubMed ID: 11410498
    [Abstract] [Full Text] [Related]

  • 13. TGF-beta signaling and collagen deposition in chronic rhinosinusitis.
    Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, Cuvelier C, Van Cauwenberge P, Bachert C.
    J Allergy Clin Immunol; 2009 Aug 15; 124(2):253-9, 259.e1-2. PubMed ID: 19500825
    [Abstract] [Full Text] [Related]

  • 14. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
    Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW.
    Arthritis Res Ther; 2007 Aug 15; 9(3):R59. PubMed ID: 17594488
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L, Malentacchi C, Campanacci D, Franchi A.
    Virchows Arch; 2002 May 15; 440(5):491-7. PubMed ID: 12021923
    [Abstract] [Full Text] [Related]

  • 16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V.
    Mol Cell Biol; 2007 Dec 15; 27(23):8228-42. PubMed ID: 17875924
    [Abstract] [Full Text] [Related]

  • 17. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 15; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 18. Abnormal transforming growth factor-beta expression in mesenchymal stem cells from patients with osteoarthritis.
    Rollín R, Alvarez-Lafuente R, Marco F, García-Asenjo JA, Jover JA, Rodríguez L, López-Durán L, Fernández-Gutiérrez B.
    J Rheumatol; 2008 May 15; 35(5):904-6. PubMed ID: 18398939
    [Abstract] [Full Text] [Related]

  • 19. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.
    Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G, Michel JB, Vranckx R.
    J Pathol; 2009 May 15; 218(1):131-42. PubMed ID: 19224541
    [Abstract] [Full Text] [Related]

  • 20. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.